ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666586 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666586; 2) Community: the network communities that were significantly associated with the response to NSC 666586; 3) Molecule: the relationships between components within communities and NSC 666586; 4) MDR: the compounds that were significantly associated with the NSC 666586.

NSC Compound Enrichment Correlation
NSC 735169 3-(3,5-Bis-trifluoromethyl-phenylsulfanyl)-1-(4-chloro-pheny l)-propenone 0.0133299224082802 0.50403655
NSC 743874 Null 0.0133299224082802 0.4380843
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0133299224082802 0.31720435
NSC 76150 Null 0.0133299224082802 0.49806494
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.0133299224082802 0.37759694
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0133299224082803 0.5028588
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0133299224082803 0.28252047
NSC 295499 Camptothecin Derivative 0.0133299224082803 0.34996297
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0133299224082803 0.62227164
NSC 48526 Null 0.0133299224082803 0.14596192
Total:95  Current:47    [First] [Prev] [Next] [Last]